Crossmark Global Holdings’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,720
| Closed | -$200K | – | 1287 |
|
|
2024
Q3 | $200K | Buy |
+4,720
| New | +$200K | ﹤0.01% | 1245 |
|
|
2023
Q3 | – | Sell |
-5,754
| Closed | -$205K | – | 1313 |
|
|
2023
Q2 | $205K | Sell |
5,754
-73
| -1% | -$2.6K | ﹤0.01% | 1248 |
|
|
2023
Q1 | $237K | Buy |
5,827
+391
| +7% | +$15.9K | 0.01% | 1154 |
|
|
2022
Q4 | $245K | Sell |
5,436
-397
| -7% | -$17.9K | 0.01% | 1100 |
|
|
2022
Q3 | $279K | Sell |
5,833
-67
| -1% | -$3.21K | 0.01% | 1023 |
|
|
2022
Q2 | $350K | Sell |
5,900
-130
| -2% | -$7.71K | 0.01% | 965 |
|
|
2022
Q1 | $701K | Buy |
6,030
+80
| +1% | +$9.3K | 0.02% | 766 |
|
|
2021
Q4 | $896K | Buy |
5,950
+4,210
| +242% | +$634K | 0.02% | 661 |
|
|
2021
Q3 | $208K | Buy |
+1,740
| New | +$208K | ﹤0.01% | 1336 |
|